|
RRAGC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.284100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.195800E-02 |
| Normal-vs-Stage2 |
8.371600E-02 |
| Normal-vs-Stage3 |
1.659250E-01 |
| Normal-vs-Stage4 |
4.625000E-01 |
| Stage1-vs-Stage2 |
7.936400E-01 |
| Stage1-vs-Stage3 |
5.553800E-01 |
| Stage1-vs-Stage4 |
3.228600E-01 |
| Stage2-vs-Stage3 |
5.423400E-01 |
| Stage2-vs-Stage4 |
3.712600E-01 |
| Stage3-vs-Stage4 |
6.373400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.277800E-02 |
| Normal-vs-AfricanAmerican |
7.637400E-01 |
| Normal-vs-Asian |
2.591000E-01 |
| Caucasian-vs-AfricanAmerican |
3.702200E-01 |
| Caucasian-vs-Asian |
8.190000E-01 |
| AfricanAmerican-vs-Asian |
5.437800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.252200E-02 |
| Normal-vs-Female |
1.015040E-01 |
| Male-vs-Female |
3.129400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.398020E-01 |
| Normal-vs-Age(41-60Yrs) |
3.437700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.762840E-01 |
| Normal-vs-Age(81-100Yrs) |
1.162400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.973200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.460400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.272200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.050800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.158600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.084400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.696000E-01 |
| Classical-VS-Follicular |
4.103600E-03 |
| Classical-VS-Other |
8.662200E-02 |
| Classical-VS-Normal |
2.201600E-01 |
| Tall-VS-Follicular |
1.292100E-02 |
| Tall-VS-Other |
3.986300E-02 |
| Tall-VS-Normal |
9.167000E-01 |
| Follicular-VS-Other |
5.147000E-01 |
| Follicular-VS-Normal |
3.981100E-03 |
| Other-VS-Normal |
3.170000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.159950E-02 |
| Normal-vs-N1 |
7.352300E-02 |
| N0-vs-N1 |
9.840600E-01 |
|
|
